WO2009063885A1 - Extrait de grifola frondosa et composition renfermant ce dernier pour favoriser la production d'acide hyaluronique (hyaluronane) - Google Patents

Extrait de grifola frondosa et composition renfermant ce dernier pour favoriser la production d'acide hyaluronique (hyaluronane) Download PDF

Info

Publication number
WO2009063885A1
WO2009063885A1 PCT/JP2008/070549 JP2008070549W WO2009063885A1 WO 2009063885 A1 WO2009063885 A1 WO 2009063885A1 JP 2008070549 W JP2008070549 W JP 2008070549W WO 2009063885 A1 WO2009063885 A1 WO 2009063885A1
Authority
WO
WIPO (PCT)
Prior art keywords
hyaluronan
production
same
hyaluronic acid
promoting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/070549
Other languages
English (en)
Japanese (ja)
Inventor
Masao Takahashi
Akira Ito
Takashi Sato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEIMAT CO Ltd
Original Assignee
HEIMAT CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEIMAT CO Ltd filed Critical HEIMAT CO Ltd
Priority to CN2008801158142A priority Critical patent/CN101854943B/zh
Priority to JP2009541142A priority patent/JP4583501B2/ja
Priority to HK11100066.6A priority patent/HK1145811B/xx
Publication of WO2009063885A1 publication Critical patent/WO2009063885A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Ophthalmology & Optometry (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne un extrait de Grifola frondosa qui favorise plus efficacement la production d'acide hyaluronique (hyaluronane) et une composition renfermant ce dernier. L'invention concerne également un extrait de G. frondosa obtenu en extrayant de la G. frondosa sèche avec de l'éthanol pur et une composition pour favoriser la production d'acide hyaluronique (hyaluronane) qui contient ce dernier.
PCT/JP2008/070549 2007-11-13 2008-11-12 Extrait de grifola frondosa et composition renfermant ce dernier pour favoriser la production d'acide hyaluronique (hyaluronane) Ceased WO2009063885A1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN2008801158142A CN101854943B (zh) 2007-11-13 2008-11-12 舞茸提取物以及含有其的用于促进透明质酸(玻尿酸)产生的组合物
JP2009541142A JP4583501B2 (ja) 2007-11-13 2008-11-12 マイタケ抽出物及びこれを含むヒアルロン酸（ヒアルロナン）産生を促進するための組成物
HK11100066.6A HK1145811B (en) 2007-11-13 2008-11-12 Grifola frondosa extract and composition containing the same for promoting the production of hyaluronic acid (hyaluronan)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-293998 2007-11-13
JP2007293998 2007-11-13

Publications (1)

Publication Number Publication Date
WO2009063885A1 true WO2009063885A1 (fr) 2009-05-22

Family

ID=40638734

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/070549 Ceased WO2009063885A1 (fr) 2007-11-13 2008-11-12 Extrait de grifola frondosa et composition renfermant ce dernier pour favoriser la production d'acide hyaluronique (hyaluronane)

Country Status (4)

Country Link
JP (1) JP4583501B2 (fr)
CN (1) CN101854943B (fr)
TW (1) TWI423810B (fr)
WO (1) WO2009063885A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014008353A2 (fr) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprenant du sulforaphane ou un précurseur de sulforaphane et un extrait ou une poudre de champignon
FR3029789A1 (fr) * 2014-12-10 2016-06-17 Greenpharma Sas Utilisation d'un extrait de papaver et composition permettant cette utilisation
WO2022251524A1 (fr) 2021-05-26 2022-12-01 Nutramax Laboratories, Inc. Compositions comprenant du sulforaphane ou un précurseur de sulforaphane et des constituants de plant de moringa

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104398425A (zh) * 2014-11-14 2015-03-11 成都鹏翔生物科技有限公司 一种含灰树花提取物的天然防晒霜
CN104323951A (zh) * 2014-11-14 2015-02-04 成都鹏翔生物科技有限公司 一种纯天然低刺激去污洁面乳及其制备方法
CN106912904B (zh) * 2017-03-15 2020-09-08 福建农林大学 一种灰树花全活性物质的制备方法及其产品

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02121905A (ja) * 1988-10-30 1990-05-09 Narisu Keshohin:Kk 化粧料
JPH11263732A (ja) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd キノコ類抽出物含有皮膚外用剤
JP2000319192A (ja) * 1999-05-03 2000-11-21 Kirindo:Kk 酵素阻害剤
JP2004501974A (ja) * 2000-07-06 2004-01-22 コグニス・フランス・ソシエテ・アノニム 菌類グリフォラ・フロンドサの抽出物の使用
WO2007142130A1 (fr) * 2006-06-02 2007-12-13 Heimat Co., Ltd. Extrait de champignon maïtake et composition contenant l'extrait destinée à augmenter la production de sébum

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01159581A (ja) * 1987-12-16 1989-06-22 Sekine:Kk 恒温減圧乾燥装置
JP2909825B2 (ja) * 1988-05-20 1999-06-23 株式会社ナリス化粧品 化粧料
JP2002034494A (ja) * 2000-07-19 2002-02-05 Maitake Hanbai Kk 乾燥きのこ
JP4078402B2 (ja) * 2002-03-08 2008-04-23 株式会社雪国まいたけ 家畜用飼料添加剤
JP2007142130A (ja) * 2005-11-18 2007-06-07 Elpida Memory Inc 露光装置及び露光方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02121905A (ja) * 1988-10-30 1990-05-09 Narisu Keshohin:Kk 化粧料
JPH11263732A (ja) * 1998-03-16 1999-09-28 Ichimaru Pharcos Co Ltd キノコ類抽出物含有皮膚外用剤
JP2000319192A (ja) * 1999-05-03 2000-11-21 Kirindo:Kk 酵素阻害剤
JP2004501974A (ja) * 2000-07-06 2004-01-22 コグニス・フランス・ソシエテ・アノニム 菌類グリフォラ・フロンドサの抽出物の使用
WO2007142130A1 (fr) * 2006-06-02 2007-12-13 Heimat Co., Ltd. Extrait de champignon maïtake et composition contenant l'extrait destinée à augmenter la production de sébum

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014008353A2 (fr) 2012-07-05 2014-01-09 Nutramax Laboratories, Inc. Compositions comprenant du sulforaphane ou un précurseur de sulforaphane et un extrait ou une poudre de champignon
EP3666277A1 (fr) 2012-07-05 2020-06-17 Nutramax Laboratories, Inc. Compositions comprenant du sulforaphane ou un précurseur de sulforaphane et un extrait ou une poudre de champignon
EP4620532A2 (fr) 2012-07-05 2025-09-24 Nutramax Laboratories, Inc. Compositions comprenant du sulforaphane ou un précurseur de sulforaphane et un extrait ou une poudre de champignon
FR3029789A1 (fr) * 2014-12-10 2016-06-17 Greenpharma Sas Utilisation d'un extrait de papaver et composition permettant cette utilisation
WO2022251524A1 (fr) 2021-05-26 2022-12-01 Nutramax Laboratories, Inc. Compositions comprenant du sulforaphane ou un précurseur de sulforaphane et des constituants de plant de moringa

Also Published As

Publication number Publication date
JP4583501B2 (ja) 2010-11-17
HK1145811A1 (en) 2011-05-06
CN101854943A (zh) 2010-10-06
CN101854943B (zh) 2012-10-10
TWI423810B (zh) 2014-01-21
TW200927157A (en) 2009-07-01
JPWO2009063885A1 (ja) 2011-03-31

Similar Documents

Publication Publication Date Title
WO2007121443A3 (fr) Différenciation des cellules progénitrices à lignées multiples et cellules épithéliales respiratoires
WO2010088633A3 (fr) Nouvelles lignées cellulaires et procédés
WO2009015343A3 (fr) Différenciation de cellules de progéniteur à multiples lignées en chondrocytes
WO2009061746A3 (fr) Procédé d'intégration de produits de départ à base de cellulose et d'amidon dans la production d'éthanol
WO2011074784A3 (fr) Couche mince à base de cu-in-zn-sn-(se,s) pour cellule solaire et procédé de préparation correspondant
PL2517286T3 (pl) Folia separatorowa, sposób jej wytwarzania, superkondensator, akumulator i kondensator zawierający taką folię
WO2010128518A3 (fr) Nouveau procédé pour la préparation de bésylate de cisatracurium
NZ593787A (en) Lyophilised dabigatran
WO2010033553A9 (fr) Expression de gènes associée à la pré-éclampsie
SG194703A1 (en) Multistage cellulose hydrolysis and quench with or without acid
WO2011156212A3 (fr) Procédé pour la dégradation des boues provenant de pâte à papier et de fabrication de papier
CL2013000634A1 (es) Composicion derivada a partir del jugo de la hoja tierna del ficus que comprende la fracción de suero del ficus; proceso para hacer una composicion de la fracción de suero de célula del ficus.
ZA201108496B (en) System for treatment of biomass to facilitate the production of ethanol
WO2009143241A3 (fr) Différenciation de cellules progénitrices de multiples lignées en cellules pancréatiques
TW200806304A (en) Maitake mushroom extract and composition containing the same for enhance production of sebum
WO2011009987A3 (fr) Dérivés d'acides auréoliques, leur procédé d'obtention et leurs utilisations
WO2010060096A3 (fr) Compositions et procédés pour augmenter la production de cellulose
WO2010083464A3 (fr) Procédés de détection de cancers du col de l'utérus
WO2010019386A3 (fr) Production de protéine dans des cellules végétales et procédés et compositions apparentés
HK1210436A1 (en) Novel cell compositions and methods
AU2008903886A0 (en) Improved "timber-finishing" process (applicable to all types of timber)
AU2009904268A0 (en) Improvement to reusable envelopes
AU2009906105A0 (en) Improvements to utility knives
AU2010280827A8 (en) Process for the preparation of 1-benzyl-3-hydroxymethyl-1H-indazole and its derivatives and required magnesium intermediates
AU2008902858A0 (en) Improvement to turning pages

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880115814.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08849250

Country of ref document: EP

Kind code of ref document: A1

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2009541142

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08849250

Country of ref document: EP

Kind code of ref document: A1